Repositorio Dspace

Listar Neurología Vascular por autor "Toni, Danilo"

Listar Neurología Vascular por autor "Toni, Danilo"

Ordenar por:Orden:Resultados:

  • Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial 
    Veltkamp, Roland C.; Pearce, Lesly A.; Korompoki, Eleni; Sharma, Mukul; Kasner, Scott E.; Toni, Danilo; Ameriso, Sebastián Francisco; Mundl, Hardi; Tatlisumak, Turgut; Hankey, Graeme J.; Lindgren, Arne; Berkowitz, Scott D.; Arauz-Gongora, Antonio; Ozturk, Serefnur; Muir, Keith W.; Chamorro, Ángel; Perera, Kanjana S.; Shuaib, Ashfaq; Rudilosso, Salvatore; Shoamanesh, Ashkan; Connolly, Stuart J.; Hart, Robert G. (American Medical Association, 2020-09-01)
    Importance: The concept of embolic stroke of undetermined source (ESUS) unifies a subgroup of cryptogenic strokes based on neuroimaging, a defined minimum set of diagnostic tests, and exclusion of certain causes. Despite ...
  • Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study 
    Perera, Kanjana S.; De Sa Boasquevisque, Danielle; Rao-Melacini, Purnima; Taylor, Amanda; Cheng, Anna; Hankey, Graeme J.; Lee, Sarah; Marti Fabregas, Joan; Ameriso, Sebastián Francisco; Field, Thalia S.; Arauz-Gongora, Antonio; Coutts, Shelagh B.; Arnold, Marcel; Mikulik, Robert; Toni, Danilo; Mandzia, Jennifer; Veltkamp, Roland C.; Meseguer, Elena; Haeusler, Karl Georg; Young ESUS Investigators (American Medical Association, 2022-05-01)
    Importance: Cryptogenic strokes constitute approximately 40% of ischemic strokes in young adults, and most meet criteria for the embolic stroke of undetermined source (ESUS). Two randomized clinical trials, NAVIGATE ESUS ...
  • Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial 
    Hart, Robert G.; Veltkamp, Roland C.; Sheridan, Patrick; Sharma, Mukul; Kasner, Scott E.; Bangdiwala, Shrikant I.; Ntaios, George; Shoamanesh, Ashkan; Ameriso, Sebastián Francisco; Toni, Danilo; Czlonkowska, Anna; Lindgren, Arne; Hankey, Graeme J.; Perera, Kanjana S.; Shuaib, Ashfaq; Coutts, Shelagh B.; Gagliardi, Rubens J.; Berkowitz, Scott D.; Mundl, Hardi; NAVIGATE ESUS Investigators (Elsevier, 2019-05-31)
    Background: Embolic stroke of undetermined source (ESUS) identifies patients with cryptogenic ischemic stroke presumed due to embolism from several unidentified sources. Among patients with recent ESUS, we sought to determine ...
  • Regional, sex, and age differences in diagnostic testing among participants in the NAVIGATE-ESUS trial 
    Arauz Gongora, Antonio; Serrano, Fabiola; Pearce, Lesly A.; Kasner, Scott E.; Ameriso, Sebastián Francisco; Toni, Danilo; Bereczki, Daniel; Siegler, James E.; Ruíz Franco, Angélica; Cantú Brito, Carlos; Czlonkowska, Anna; Lang, Wilfried; Berkowitz, Scott D.; Mundl, Hardi; Hart, Robert G. (Sage, 2019-10-20)
    BACKGROUND AND AIM: The diagnosis of embolic stroke of undetermined source (ESUS) is based on excluding other more likely stroke etiologies, and therefore diagnostic testing plays an especially crucial role. Our objective ...
  • Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudy 
    Sharma, Mukul; Smith, Eric E.; Pearce, Lesly A.; Perera, Kanjana S.; Kasner, Scott E.; Yoon, Byung-Woo; Ameriso, Sebastián Francisco; Puig, Josep; Damgaard, Dorte; Fiebach, Jochen B.; Muir, Keith W.; Veltkamp, Roland C.; Toni, Danilo; Shamalov, Nikolay; Gagliardi, Rubens J.; Mikulik, Robert; Engelter, Stefan T.; Bereczki, Daniel; O'Donnell, Martin J.; Saad, Feryal (Sage, 2021-11-18)
    Background Covert brain infarcts are associated with important neurological morbidity. Their incidence in patients with embolic stroke of undetermined source (ESUS) is unknown. Aims To assess the incidence of covert ...
  • Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial 
    Sharma, Mukul; Molina, Carlos A.; Toyoda, Kazunori; Bereczki, Daniel; Bangdiwala, Shrikant I.; Kasner, Scott E.; Lutsep, Helmi L.; Tsivgoulis, Georgios; Ntaios, George; Czlonkowska, Anna; Shuaib, Ashfaq; Amarenco, Pierre; Endres, Matthias; Yoon, Byung Woo; Tanne, David; Toni, Danilo; Yperzeele, Laetitia; von Weitzel Mudersbach, Paul; Sampaio Silva, Gisele; Ameriso, Sebastián Francisco (Lancet Pub. Group, 2024-01)
    Background: People with factor XI deficiency have lower rates of ischaemic stroke than the general population and infrequent spontaneous bleeding, suggesting that factor XI has a more important role in thrombosis than in ...

Buscar en DSpace


Listar

Mi cuenta